Co-Authors
This is a "connection" page, showing publications co-authored by Anu Osinusi and Huyen Cao.
Connection Strength
0.340
-
Compassionate Use of Remdesivir in Children With Severe COVID-19. Pediatrics. 2021 05; 147(5).
Score: 0.059
-
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor. Clin Pharmacokinet. 2021 05; 60(5):569-583.
Score: 0.059
-
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 09 15; 324(11):1048-1057.
Score: 0.056
-
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects. Clin Transl Sci. 2020 09; 13(5):896-906.
Score: 0.056
-
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020 11 05; 383(19):1827-1837.
Score: 0.055
-
Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020 06 11; 382(24):2327-2336.
Score: 0.055